Lightnews — Scholar-powered news

Sayna Norouzi, MD @saynanorouzi.bsky.social · 16d

Huge thank you to our incredible faculty, attendees, sponsors, and GlomCon instructors for making #GlomConHawaii conference a success! 🌟
We deeply appreciate and value your partnership.
Hope to see you all next year, in Maui August 3-7 ⭐️

Mahalo!! 🌺
@glomcon.org

1 1

Sayna Norouzi, MD @saynanorouzi.bsky.social · 16d

Huge thank you to our incredible faculty, attendees, sponsors, and GlomCon instructors for making #GlomConHawaii conference a success! 🌟
We deeply appreciate and value your partnership.
Hope to see you all next year, in Maui August 3-7 ⭐️

Mahalo!! 🌺

1

Sayna Norouzi, MD @saynanorouzi.bsky.social · 21d

What a fantastic evening at the #GlomConHawaii reception! Thank you to everyone who joined us🥰
It’s a privilege to be part of such an exceptional community. The future of nephrology is bright. @glomcon.org

3 9

Reposted by Sayna Norouzi, MD

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 22d

Excellent thread below

I will also plug this talk by Paola Romagnani on podocytopathies

youtu.be/bRMeqaGgA9I?...

#GlomCon #NephGR

5 11

Reposted by Sayna Norouzi, MD

glomcon.org @glomcon.org · May 15

Register here 👉 glomconhawaii.org

#GlomConHawaii2025
#GlomConHawaii
#GlomCon

Home | GlomCon Hawaii

GlomCon Hawaii is an annual in-person and hybrid conference dedicated to advancing education, research, and collaboration in nephrology. As part of GlomCon Foundation's initiative, the conference brin...

glomconhawaii.org

2 4

Reposted by Sayna Norouzi, MD

glomcon.org @glomcon.org · Feb 25

This year’s in-person gathering promises to strengthen connections, spark deeper collaboration, and elevate the learning experience in beautiful Hawaii.

Can't join us in person? We plan to live-stream the main sessions; see you on the virtual side.

#GlomConHawaii
#GlomCon

glomcon Event

Enjoy the event with us!

bit.ly

1 2

Reposted by Sayna Norouzi, MD

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 23d

Clinical Endpoints for Glomerular Diseases from
@hjanders.bsky.social
#GlomConHawaii 🌊 #Nephpearls #NephSky

2 7

Reposted by Sayna Norouzi, MD

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · Aug 7

IgA Nephropathy #IgAN: An Overview of the Clinical Trials ca. 2025 from @saynanorouzi.bsky.social
#Nephpearls #NephSky

www.kidneymedicinejournal.org/article/S259...

IgA Nephropathy: An Overview of the Clinical Trials

IgA nephropathy (IgAN) is characterized by the deposition of poorly-O-galactosylated IgA1 (also referred to as galactose-deficient IgA1 or gd-IgA1) containing immune complexes in the glomerular mesang...

www.kidneymedicinejournal.org

1 8

Sayna Norouzi, MD @saynanorouzi.bsky.social · Aug 1

Thank you 🙌🏻

1

Reposted by Sayna Norouzi, MD

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · Jul 2

Congrats @sophia-kidney.bsky.social @saynanorouzi.bsky.social @kashvilunawat.bsky.social

And all the other awardees of the @asnkidney.bsky.social NephCure grants!

www.kidneycure.org/pages/qa.aspx

KidneyCure | Spotlights/Q&A - Who We Fund

Learn more about who KidneyCure funds.

www.kidneycure.org

2 5 13

Sayna Norouzi, MD @saynanorouzi.bsky.social · Jun 21

Thank you!! Always a pleasure to collaborate with you.

2

Reposted by Sayna Norouzi, MD

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · Jun 21

It’s not just the immune mediated and infections - we need to pay attention to cardiovascular disease in SLE

pubmed.ncbi.nlm.nih.gov/40539000/

Nice job synthesizing the data @saynanorouzi.bsky.social and team!

#NephSky #lupuschat

Cardiovascular Events in Lupus Nephritis: A Systematic Review and Meta-Analysis - PubMed

CVE occurrence among individuals with LN is significant, and this disease entity increases CVE risk, highlighting the importance of implementing early therapeutic interventions to prevent poor outcome...

pubmed.ncbi.nlm.nih.gov

1 11 21

Reposted by Sayna Norouzi, MD

glomcon.org @glomcon.org · Jun 6

#GlomConHawaii 2025 🌴🌊 session:
Post-market Evaluations, Registries, and RWE Studies

Register here 👉 glomconhawaii.org

#GlomConHawaii2025
#GlomConHawaii
#GlomCon

1 1 2

Sayna Norouzi, MD @saynanorouzi.bsky.social · Jun 10

Thank you🥰

1

Reposted by Sayna Norouzi, MD

Izabela Zakrocka @izabelazakrocka.bsky.social · Jun 5

@saynanorouzi.bsky.social rocks in Vienna #ERA25! @glomcon.org

2 4 7

Reposted by Sayna Norouzi, MD

glomcon.org @glomcon.org · May 5

🚨 Exciting News! 🚨
The GlomCon Foundation, American Kidney Fund, and
IgA Nephropathy Foundation have joined forces to develop the consensus framework for establishing Centers of Excellence in Glomerular Disease Care!

🔗 Learn more: www.glomcon.org/news-release...

1 2 3

Reposted by Sayna Norouzi, MD

glomcon.org @glomcon.org · May 1

Applications are now open for the Polycystic Kidney Disease Medical Directorship Program (PKD-MDP)! 🤩

🔗 Apply here: www.glomcon.org/pkdmd-program
📅 Deadline to apply is July 15, 2025

1 4 3

Reposted by Sayna Norouzi, MD

HCPLive @hcplivenews.bsky.social · Apr 26

Q1 was full of important advances in #nephrology, especially in glomerular diseases. Hear from @SaynaNorouzi @LLUHealth @GlomCon as she reflects on some of these developments and looks ahead to what might be in store for the rest of 2025:

www.hcplive.com/view...

What’s New and What’s Next in Glomerular Disease Care, with Sayna Norouzi, MD

Norouzi reflects on significant advances in glomerular disease from Q1 and looks ahead to what the rest of 2025 may have to offer.

www.hcplive.com

1 1

Reposted by Sayna Norouzi, MD

Sayna Norouzi, MD @saynanorouzi.bsky.social · Feb 26

Are you effectively preventing VTE in your patients with nephrotic syndrome?

Check out our paper below on KI reports about this important topic. It's a fantastic collaboration with some truly brilliant minds! #NephSky @glomcon.org

www.kireports.org/article/S246...

Venous thromboembolism prevention for nephrotic syndrome: The role of aspirin, vitamin K antagonists and direct oral anticoagulants

Nephrotic syndrome (NS) carries a significantly elevated risk of venous thromboembolic events (VTE), contributing to morbidity and mortality. Current guidelines for VTE prophylaxis in NS are based on ...

www.kireports.org

1 10 16

Reposted by Sayna Norouzi, MD

glomcon.org @glomcon.org · Apr 16

GlomCon is thrilled to introduce a new leadership training opportunity 🤩

The Polycystic Kidney Disease Medical Directorship Program (PKD-MDP) is a year-long, interactive program aiming to deepen participants' expertise in PKD diagnosis and management.

Applications open May 1.

1 1 2

Sayna Norouzi, MD @saynanorouzi.bsky.social · Apr 8

Smoking-modified HTN-associated nodular glomerulosclerosis (SHaNGS), a form of hypertensive glomerulosclerosis in the context of alteration by smoking products.

pmc.ncbi.nlm.nih.gov/articles/PMC11…

Reposted by Sayna Norouzi, MD

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · Apr 3

Venous Thromboembolism Prevention in Nephrotic Syndrome: The Role of Aspirin, Vitamin K Antagonists, and Direct Oral Anticoagulants ca. 2025 from @kireports.bsky.social @saynanorouzi.bsky.social @kdjhaveri.bsky.social
#Nephpearls #NephSky

👉 www.kireports.org/article/S246...

3 3 8

Sayna Norouzi, MD @saynanorouzi.bsky.social · Apr 4

In August 2024, GlomCon launched its 1st international hybrid conference on GN in Maui.

Diverse group of expert faculty of 52 members, achieving an intentional and balanced gender representation of 50% male and 50% female. The event reached a total of 619 registrations.

karger.com/gdz/article/5/…

https://karger.com/gdz/article/5/…

Sayna Norouzi, MD @saynanorouzi.bsky.social · Apr 4

The FDA approved inebilizumab-cdon (UPLIZNA; @Amgen as the first and only treatment for adult patients diagnosed with immunoglobulin G4-related disease (IgG4-RD). #RareDiseases
pubmed.ncbi.nlm.nih.gov/39969992/

IgG4-Related Kidney Disease - PubMed

IgG4-Related Kidney Disease

pubmed.ncbi.nlm.nih.gov

2 4